CoronaVac

Vaccine against COVID-19

CoronaVac ▸ Facts ▸ Comments ▸ News ▸ Videos

CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. It was Phase III clinical trialled in Brazil, Chile, Indonesia, the Philippines, and Turkey and relies on traditional technology similar to other inactivated-virus COVID-19 vaccines, such as the Sinopharm BIBP vaccine, another Chinese vaccine, and Covaxin, an Indian vaccine. CoronaVac does not need to be frozen and both the final product and the raw material for formulating CoronaVac can be transported refrigerated at 2–8 °C (36–46 °F), temperatures at which flu vaccines are kept.

0 shares	Share Tweet Save Post Send

You Might Like

Canada set to recognise Covaxin from Nov 30 In a big relief to travellers from India, Canada will recognise Bharat Biotech's Covaxin from November 30. It has expanded its list of WHO-approved Covid-19 vaccines that will be accepted for travel to.. IndiaTimes - Published on November 20, 2021
Covishield approved by Australia for international arrivals Australia has approved India-made Covishield for travelling into the country. The Therapeutic Goods Administration has advised that the China-made Sinovac and the India-made Covishield vaccines would.. IndiaTimes - Published on October 1, 2021
North Korea declines offer of three million COVID-19 vaccines, says UNICEF North Korea has rejected about three million doses of China's Sinovac coronavirus vaccine, UNICEF has said. Sky News - Published on September 1, 2021